ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)

August 15, 2024 1:00 PM

CHICAGO, IL / ACCESSWIRE / August 15, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT) applauds the U.S. Food and Drug Administration's (FDA) approval of axatilimab-csfr (Niktimvo, Incyte Corporation), a significant new therapy for patients suffering from chronic graft-versus-host disease (cGVHD). This approval represents a major advancement in the treatment of this severe and often debilitating condition, which...

Read more

CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product

August 15, 2024 12:55 PM

CALGARY, AB / ACCESSWIRE / August 15, 2024 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has received three purchase orders for cannabis, for a total of 600KG, from Cantek Holdings. These orders are related to a previously announced supply agreement, and we are happy to announce that the market has proven to be pleased with our quality craft growing...

Read more

PMDS preliminary P&L results ahead of Q2 Interim Report

August 15, 2024 11:45 AM

STOCKHOLM, SE / ACCESSWIRE / August 15, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) Financial information April - June 2024 (figures in brackets relate to the same period in Q2 2023). These are preliminary results of the P&L statement; the final results will be published in the Q2 Interim report on on August 22nd.Consolidated net sales increased by 30.9%, which is in line with expectations at kSEK 12,354 (9,440), which was contributed by the...

Read more

Advanced eClinical Ranked #1 on Forbes Education’s Best CMA Certification Online List

August 15, 2024 11:15 AM

Advanced eClinical Training (ACT) is proud to announce its top ranking on Forbes Education's prestigious Best CMA Certification Online list for 2024. This recognition is a testament to the institution's unwavering commitment to providing superior education and training for future healthcare professionals.Forbes Education's annual ranking evaluates online Certified Medical Assistant (CMA) programs based on a comprehensive set of criteria...

Read more

SFWJ/MedCana Will Eliminate All Convertible Debt by the End of the 3rd Quarter

August 15, 2024 10:15 AM

SFWJ, doing business as Medcana, a holding company focused in the cannabis and agricultural technology sectors, is pleased to announce all Convertible Debt on the Company's Balance sheet will be eliminated and reported in the 3rd Quarter Financial Report.As the Company prepares to enter its next growth phase, the debtholders worked out a deal to swap the debt for Preferred shares with the same rights and interest rate to boost investor...

Read more

Forum Health, Top Healthcare Network, Earns Inc. 5000 Honors Again, Boasting 286% Revenue Growth

August 15, 2024 9:15 AM

Forum Health, LLC, a premier nationwide provider of personalized integrative healthcare, is thrilled to announce its recognition on the Inc. 5000 list of America's Fastest Growing Companies for the second consecutive year.Securing a ranking of #1829 overall and #137 within the healthcare sector, Forum Health's growth is driven by surging consumer demand for innovative solutions, pioneering medical treatments, and the acquisition of top-tier...

Read more

DEXIS Launches DEXIS Connect Pro, a New Proactive Service Platform for DEXIS CBCT and Intraoral Sensor Devices, Focused on Increasing Device Uptime

August 15, 2024 9:00 AM

QUAKERTOWN, PA / ACCESSWIRE / August 15, 2024 / DEXIS™ Connect Pro proactively monitors the health of DEXIS CBCT and intraoral sensor devices through IoT technology and can automatically arrange support or equipment replacements if performance issues are detected, allowing customers' DEXIS products to stay up and running more consistently. "The ability to ensure top performance of our equipment in the field has increased the level of customer...

Read more

First Licensed Adult-Use Cannabis Dispensary in New Rochelle is Woman Owned and Ready to Help Educate the Community

August 15, 2024 9:00 AM

NEW ROCHELLE, NY / ACCESSWIRE / August 15, 2024 / Highlife Health, LLC, a Woman Owned, licensed adult-use cannabis dispensary announces their grand opening/consumer education event will take place on August 31, 2024. "It is a privilege to establish Highlife Health LLC in my hometown and setting a precedent for our community that women can thrive and carve their own path in any industry," said Jennifer Gierum, President/CEO of Highlife Health...

Read more

Medical Component Specialists Expands Quick Ship Program

August 15, 2024 9:00 AM

BELLINGHAM, MA / ACCESSWIRE / August 15, 2024 / For medical device manufacturers, having the right suppliers ensures necessary components can be obtained whenever needed. For this reason, Medical Component Specialists' Quick Ship Program provides next-day shipping for over 400 catheter-forming mandrels and raw materials.Quick Ship Product Announcement Recently, the Quick Ship Program expanded to include PTFE GLASS filled and Nitinol...

Read more

Sagesse Bio Accelerates Development of SGY-101 into clinical development for Targeted Fat Reduction in Aesthetic Medicine and Medical Dermatology

August 15, 2024 9:00 AM

Sagesse Bio, an early-stage pharmaceutical company in aesthetic medicine and medical dermatology with a focus on body contouring and focal fat reduction announces its plans to rapidly develop its lead asset SGY-101 with backing from Gore Range Capital LLC (Gore Range Capital), a leading healthcare investment firm and Sirnaomics LTD (Sirnaomics), a leader in RNAi technology. Gore Range Capital will contribute its expertise in the skin health...

Read more

Scientific Industries Reports Second Quarter 2024 Results

August 15, 2024 9:00 AM

Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, yesterday reported financial results for the three and six month periods ended June 30, 2024.Business Highlights:The Company's newly launched Bioprocessing DOTS MPS gains market traction.The Company introduced the VIVID Workstation at major trade shows.John Nicols, Chairman of SBI and Board member, was a guest...

Read more

Communication Service for the Deaf, Inc. Receives $250,000 Engagement Award from PCORI

August 15, 2024 8:30 AM

AUSTIN, TX / ACCESSWIRE / August 15, 2024 / Communication Service for the Deaf, Inc. (CSD) has been awarded $250,000 through the Eugene Washington PCORI Engagement Award Program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI). The funding will support a two-year project titled "Building Capacity for Deaf American Sign Language Users in Virtual Healthcare PCOR/CER," running from November 1, 2024 through October 31,...

Read more

CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results

August 15, 2024 8:00 AM

HOUSTON, TX / ACCESSWIRE / August 15, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the second quarter 2024 ended June 30, 2024."It has been an important year for CNS Pharmaceuticals with completion of enrollment in our...

Read more

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

August 15, 2024 7:30 AM

Closed new licensing agreement with GSK worth up to €1.45 billion, including €400 million upfront; provides strong validation of CureVac's mRNA platformInitiated strategic workforce reduction of ~30% by end of 2024, optimizing business to focus on high-value opportunities in oncology, infectious diseases and other areasInvoiced €10 million milestone payment after Phase 2 transition of pre-pandemic avian influenza (H5N1) program; candidate fully...

Read more

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

August 15, 2024 7:20 AM

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / August 15, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced the start of the dose-confirmation Part B of its ongoing Phase 1 study in patients with resected glioblastoma. CVGBM is CureVac's first investigational cancer vaccine based on its proprietary...

Read more

CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board

August 15, 2024 7:15 AM

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / August 15, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today named clinical oncologist Mehdi Shahidi, M.D., as an independent director to the company's Supervisory Board. Dr. Shahidi replaces Ralf Clemens, who served on the Supervisory Board from March 2016 through...

Read more

Beta Bionics Celebrates Milestone: 10,000th iLet Patient

August 15, 2024 7:00 AM

CONCORD, MA / ACCESSWIRE / August 15, 2024 / Beta Bionics, a commercial-stage medical technology company, proudly announces the 10,000th patient start on the iLet Bionic Pancreas. This significant milestone marks a major step forward in the company's mission to alleviate the daily burden of diabetes management for patients and healthcare providers alike.iLet With Dexcom G7 The iLet Bionic Pancreas is the first FDA-cleared autonomous closed-loop...

Read more

BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations

August 15, 2024 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report that it has signed a non-binding letter of intent (the "LOI") with German-based international contract research, development, and manufacturing company Gen-Plus GmbH & Co KG ("Gen-Plus"), a part of Conscio Group.Further to the Master Service Agreement and Cladribine Statement of Work signed by BioNxt and Gen-Plus announced on July 9, 2024, and...

Read more

Half-Year Report 2024: Orviglance Completes Clinical Development with Successful Phase 3 Study

August 15, 2024 1:50 AM

MALMÖ, SWEDEN / ACCESSWIRE / August 15, 2024 / Ascelia Pharma (STO:ACE) Ascelia Pharma AB (publ) (ticker: ACE) today published its Half-Year Report for 2024 (January - June), which is now available on the company's website: https://www.ascelia.com/ir-media/financial-reports/KEY EVENTS IN Q2 2024SPARKLE image reading completed with expected headline results first half of May 2024Ascelia Pharma draws down SEK 15 million second tranche under...

Read more

NHI Announces Pricing of Upsized Public Offering of Common Stock

August 14, 2024 9:00 PM

National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today the pricing of an underwritten public offering of 2,400,000 shares of its common stock at a public offering price of $71.25 per share, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters were also granted a 30-day...

Read more